| Date Filed | Type | Description |
| 01/18/2023 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 26,668 shares
@ $0 |
|
| 06/22/2022 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 34,300 options to buy
@ $4.74, valued at
$162.6k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2021 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 12,840 shares
@ $0 |
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
3
| FRIEDMAN PAUL A (Director) has filed a Form 3 on Prelude Therapeutics Inc |
| 05/28/2020 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,282 shares
@ $0
Granted 10,514 options to buy
@ $98.68, valued at
$1M
|
|
| 05/18/2020 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 3,468 shares
@ $0 |
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
SC 13D/A
| FRIEDMAN PAUL A reports a 7.4% stake in Madrigal Pharmaceuticals, Inc. |
| 08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2019 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,726 shares
@ $0 |
|
| 04/29/2019 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,520 shares
@ $0
Granted 12,472 options to buy
@ $75.03, valued at
$935.8k
|
|
| 03/11/2019 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $127.96, valued at
$6.4M
|
|
| 11/23/2018 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Bought 4,000 shares
@ $117.88, valued at
$471.5k
|
|
| 11/19/2018 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Bought 4,000 shares
@ $124, valued at
$496k
|
|
| 06/12/2018 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 73,526 shares
@ $287.46, valued at
$21.1M
|
|
| 05/11/2018 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,174 shares
@ $0 |
|
| 05/03/2018 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 15,000 options to buy
@ $60.85, valued at
$912.8k
|
|
| 03/05/2018 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $124.45, valued at
$6.2M
|
|
| 11/30/2017 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 1,977 shares
@ $0 |
|
| 11/20/2017 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 28,507 shares
@ $105.24, valued at
$3M
|
|
| 09/22/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Cerulean Pharma Inc. |
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Cerulean Pharma Inc. |
| 10/20/2016 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Cerulean Pharma Inc. |
| 08/01/2016 |
SC 13D
| FRIEDMAN PAUL A reports a 8.2% stake in Madrigal Pharmaceuticals, Inc. |
|